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Abstract
Bone formation or regeneration requires the recruitment, proliferation, and osteo-
genic differentiation of stem/stromal progenitor cells. A potent stimulus driving this
process is mechanical loading. Osteocytes are mechanosensitive cells which play fun-
damental roles in coordinating loading-induced bone formation via the secretion of
paracrine factors. However, the exact mechanisms by which osteocytes relay
mechanical signals to these progenitor cells are poorly understood. Therefore, this
study aimed to demonstrate the potency of the mechanically stimulated osteocyte
secretome in driving human bone marrow stem/stromal cell (hMSC) recruitment and
differentiation, and characterize the secretome to identify potential factors regulating
stem cell behavior and bone mechanobiology. We demonstrate that osteocytes sub-
jected to fluid shear secrete a distinct collection of factors that significantly enhance
hMSC recruitment and osteogenesis and demonstrate the key role of extracellular
vesicles (EVs) in driving these effects. This demonstrates the pro-osteogenic potential
of osteocyte-derived mechanically activated extracellular vesicles, which have great
potential as a cell-free therapy to enhance bone regeneration and repair in diseases
such as osteoporosis.
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1 | INTRODUCTION
Osteocytes are the most abundant cell type in bone and are known as
the primary sensing and metabolism-controlling cells within the tissue.
Osteocytes are key to directing the processes of bone formation and
resorption via the secretion of various signaling factors which act
upon bone forming osteoblasts and resorbing osteoclasts and their
progenitors, skeletal, and hematopoietic stem cells.1 The implications
of this can be seen in the highly debilitating and life-threatening dis-
ease that is osteoporosis, which has been linked to osteocyte apopto-
sis2 and reduced osteocyte numbers in affected patients.3 This results
in a significant drop in quality of life, increased risk of additional com-
plications due to immobilization, and significantly increased mortality
rates due to fracture and secondary causes.4 Not only do osteocytes
have key functions in bone, but they have also been shown to be
involved in a large range of other major functions throughout the
body,5 including heart, muscle and liver function, and suppressing
breast cancer growth and metastasis in bone.6 This highlights the criti-
cal role of the osteocyte in human health, and the importance of bet-
ter understanding osteocyte signaling factors for the development of
therapeutics to treat orthopedic and systemic diseases.
A prime example of osteocyte sensing and coordination of bone
physiology is in mechanoadaptation, with mechanical loading leading
to enhanced bone formation and unloading leading to bone loss.7 In
response to macroscale deformation of bone, resident osteocytes
sense the micromechanical environment consisting of oscillatory fluid
flow-induced shear stress and relay this biophysical signal to effector
cells.8 Mechanically stimulated osteocytes can enhance the bone for-
ming capacity of osteoblasts via direct cell-cell contact,9 in addition to
secreted factors as demonstrated by conditioned media experi-
ments.10,11 Furthermore, this same mechanically activated osteocyte
conditioned media was also shown to inhibit osteoclast formation.12,13
Due to the nonproliferative state and short life span of mature bone
cells, continuous bone formation requires the replenishment of the
exhausted osteoblast from a stem cell or progenitor population.14
Interestingly, the osteocyte has also been shown to coordinate bone
marrow stem/stromal cell (MSC) behavior, with conditioned media
from mechanically stimulated osteocytes enhancing stem cell prolifer-
ation, recruitment, and osteogenic differentiation, demonstrating the
far reaching influence of this cell type, particularly in response to a
mechanical stimulus.10
The means by which osteocytes coordinate this mechanoadaptation
of bone is of great interest, with several key factors identified as
playing a role in this regard and, therefore, targeted as therapeutics.
There has been a plethora of studies investigating various osteocyte-
derived factors released in response to fluid shear, including nitric
oxide (NO), prostaglandin E2, ATP, RANKL, osteoprotegerin (OPG),
and macrophage colony-stimulating factor (M-CSF).1 One factor that
has gained much interest is sclerostin (SOST) which is released by
osteocytes and inhibits Wnt-mediated bone formation. SOST expres-
sion is inhibited following mechanical loading and inhibition of this
protein via anti-sclerostin therapy has been shown in clinical trials to
increase bone mineral density and reduce fracture risk.15 To gain a
greater understanding of the factors expressed by physically stimu-
lated osteocytes, others have taken a more global approach, using
microarrays to study global gene expression in osteocytes sub-
jected to cyclic compressive forces16 and osteocytes isolated from
murine trabecular bone following vertebrae loading.17 Furthermore,
a proteomic analysis has been combined with a transcriptomic anal-
ysis of osteocytes subjected to fluid shear to investigate protein as
well as gene expression information and reveal novel interactions
between them.18 These studies revealed the altered proteome of
the osteocyte, due to fluid flow stimulation, and identified a range
of proteins which may be involved in mechanotransduction, includ-
ing nucleoside diphosphate kinase and calcyclin, which are of inter-
est due to their roles in ATP and calcium-binding, respectively.
However, to date, the full secretome protein signature of the oste-
ocyte and how this is altered in response to mechanical stimulation
is unknown.
A route of cell-cell communication which has garnered much
attention of late is via extracellular vesicles (EVs). EVs are spherical
proteolipids bilayer surrounded vesicles secreted from cells and are
involved in cell-cell communication. EVs can transfer cargo including
lipids, proteins, and nucleic acid from one cell to another, thereby
influencing the recipient cell function.19 Interestingly, it has recently
been shown that bone cells release EVs and use these vesicles as a
mechanism to mediate osteoblast and stem cell osteogenesis.20-24
Moreover, osteocyte-derived EVs contain miRNAs known to mediate
osteoblast function, highlighting a potential nonprotein based role in
bone cell communication.25,26 Bone derived EVs may also be
exploited as a potential therapy for various diseases, as well as having
potential for treatment of critical size bone defects.27 In addition, the
capability to load EVs with factors to guide cell behavior both in vitro
and in vivo has been shown,28 supporting their potential as a powerful
drug delivery method. Interestingly, the release of EVs—and thus their
content—may also be altered by mechanical loading. In fact, EV
release into plasma increases following exercise, with a differential
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protein cargo in EVs from subjects after exercise compared to those
at rest.29 In summary, the importance of the role EVs play in osteo-
genesis can be seen, and due to the dynamic nature of this tissue,
indicate potential further mechanisms involving EVs in bone
mechanoadaptation.
While changes in several factors in and released by osteocytes
have been shown via proteomics analysis, the specific composition
and factors implicated in mechanically mediated osteocyte paracrine
signaling are yet to be elucidated. Thus, the aim of this study was to
further investigate the means by which osteocytes mediate bone
mechanoadaptation, with this being achieved by constructing, for
the first time, an extensive map of the osteocyte secretome protein
signature. This map comprises the relative expression of hundreds of
proteins in the osteocyte proteome under static and dynamic condi-
tions in addition to providing information on how they interact with
one another. We first validated the ability of the osteocyte secret-
ome to induce a chemotactic and osteogenic response in human
bone marrow stem/stromal cells (hMSCs) using a parallel plate flow
chamber approach to mechanically stimulate osteocytes. We then
conducted a proteomic analysis on the osteocyte secretome via mass
spectrometry, to identify proteins released by cells under both static
and dynamic culture conditions. Enrichment of gene ontology terms
was investigated to elucidate the primary cellular components and
processes with which the osteocyte secretome is involved, with fur-
ther analysis comparing the altered protein release and most differ-
entially expressed proteins released by mechanically stimulated cells.
This led to the discovery of MA-EVs. Specifically, EVs were subse-
quently separated from the secretome of mechanical-activated oste-
ocyte; characterised; and found to elicit similar trends in MSC
recruitment and osteogenesis to that seen with conditioned media
(ie, whole secretome). We further demonstrated how MA-EVs drove
enhanced later term osteogenesis as assessed by alkaline phospha-
tase (ALP) activity. This demonstrated a key role for osteocyte EVs
in mediating hMSC behavior, identifying a potential novel mecha-
nism by which osteocytes coordinate loading-induced bone
formation.
2 | MATERIALS AND METHODS
2.1 | Cell culture
MLO-Y4 osteocyte like cells (Kerafast)30 were cultured, as previously
described,31 in α-MEM growth medium with 2.5% fetal bovine serum
(FBS, lot #11307, Biosera), 2.5% calf serum (CS, lot #10406, Biosera),
1% penicillin/streptomycin (PS), and 1% L-glutamine during static cul-
ture and fluid shear stimulation. For whole secretome/conditioned
medium (CM) studies, cells were cultured in α-MEM with 1% PS and
1% L-glutamine. hMSCs were isolated from bone marrow (Lonza),
characterized by tri-lineage differentiation (data not shown), and
maintained in Dulbecco's modified eagle medium with 10% FBS and
1% PS unless otherwise stated. All cells were cultured at 37C and
5% CO2.
2.2 | Mechanical stimulation and conditioned
medium collection
Forty-eight hours prior to fluid shear application, 75 × 38 mm glass slides
were coated with 0.15 mg/mL type I collagen (Sigma C3867) for 1 hour
and washed with phosphate buffered saline (PBS), after which osteo-
cytes were seeded at a density of 1.16 × 104 cells/cm2. Glass slides were
transferred to custom-made parallel plate flow chambers (PPFCs) as pre-
viously described.32 Each glass slide was assembled within an individual
PPFC under sterile conditions and incubated at 37C and 5% CO2. Cells
in PPFCs were either subjected to a fluid shear stress of 1 Pa at a fre-
quency of 1 Hz, or maintained in the PPFC under static conditions, with
each condition completed in quadruplicate. After 2 hours of treatment,
slides were transferred to culture dishes, washed with PBS, and 2.5 mL
of serum-free medium was applied. A control group consisting of colla-
gen-coated glass slides with no cells was also incubated with 2.5 mL of
serum-free medium. All culture dishes were incubated for 24 hours and
medium was collected from cells which had undergone fluid shear (CM-
F), statically cultured cells (CM-S) and from cell-free slides with collagen
coating (Medium). Samples were centrifuged at 3000g for 10 minutes at
4C to remove debris, after which the supernatant was collected and
stored at −80C prior to use (Figure 2A).
2.3 | Effect of osteocyte conditioned media on
bone marrow stem/stromal cell recruitment
Chemotaxis of hMSCs was assessed using Boyden chambers with a
pore size of 8 μm (Merck Millipore, PIEP12R48). Cells were seeded on
the upper membrane in serum-free α-MEM medium at a density of
30 000 cells/cm2 and allowed to adhere 4 hours before being trans-
ferred to the wells containing chemotactant (Medium [serum-free],
CM-S, CM-F, Medium + 10% FBS). Cells were then cultured for a fur-
ther 18 hours, fixed with 10% formalin solution, and stained with
hematoxylin. Light microscopy was used to determine the number of
migrated cells, which was then normalized to Medium for each group.
2.4 | Effect of osteocyte conditioned media on
bone marrow stem/stromal cell osteogenesis
hMSC cells were seeded in 6-well plates at a density of 6500 cells/cm2
and cultured for 24 hours. Osteocyte CM (CM-S, CM-F) was then
applied and hMSCs were cultured for a further 24 hours after which
time cells were lysed with tri-reagent (Sigma Aldrich) and mRNA iso-
lated as per the manufacturer's protocol. RNA concentration was mea-
sured using a Nanodrop spectrophotometer and sample purity was
checked via 260/280 and 260/230 absorbance ratios. Two hundred
nanograms RNA was reverse transcribed to cDNA using a High-Capac-
ity cDNA Reverse Transcription Kit (Applied Biosystems). Commercially
available primers (Sigma Aldrich, KSPQ12012) were used to determine
levels of cyclooxygenase 2 (COX2), osteocalcin (OCN), osteopontin
(OPN), runt-related transcription factor 2 (RUNX2), and osterix (OSX)
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(Table S1). Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) and
18S were used as reference genes for this study. Quantitative polymer-
ase chain reaction (qPCR) analysis was performed using a reaction vol-
ume of 20 μL containing 10 μL SYBR green PCR MasterMix
(Invitrogen, Ltd, Paisley, UK), 0.8 μL of each forward and reverse
primer, and 8.4 μL DNase-free water. Plates were run on an ABI 7500
Fast real-time PCR system (Life Technologies, Carlsbad, California).
2.5 | Sample preparation for mass spectrometry
(MS) analysis
Protein precipitation was carried out with 1 mL of each sample
(Medium, CM-S, CM-F) using trichloroacetic acid, and, following cen-
trifugation at 18 500g, the pellet resuspended in 6 M urea in 50 mM
ammonium bicarbonate. Samples were reduced with 5 mM
dithiothreitol for 30 minutes at 60C and alkylated with 10 mM
iodoacetamide for 30 minutes at room temperature in the dark, after
which ammonium bicarbonate was added to bring the concentration
of urea to 1.8 M. The reduced and alkylated proteins were then
digested overnight with trypsin at a ratio of 1:50 wt/wt trypsin to
protein at 37C and 350 rpm on a Thermomixer. Digestion was then
stopped with 8.8 M hydrochloric acid. Peptides were bound and
desalted using C18 ZipTips (Merck Millipore) and washed with 0.1%
trifluoroacetic acid (TFA) before being resuspended in 10 μL elution
solution (50% acetonitrile in 0.1% TFA). Samples were concentrated
using a SpeedVac vacuum concentrator until roughly 4 μL remained,
before being resuspended in 20 μL 0.5% acetic acid (Figure 2B).
2.5.1 | Liquid chromatography-mass spectrometry
and tandem mass spectrometry (LC MS/MS) analysis
Biological samples (n = 3) were run with two technical replicates on a
Thermo Scientific Q Exactive mass spectrometer connected to a
Dionex Ultimate 3000 (RSLCnano) chromatography system. Each
sample was loaded onto a fused silica emitter (75 μm ID, pulled using
a laser puller [Sutter Instruments P2000]), packed with UChrom C18
(1.8 μm) reverse phase media (nanoLCMS Solutions LCC) and was
separated by an increasing acetonitrile gradient over 47/60 minutes
at a flow rate of 250 nL/min. The MS was operated in positive ion
mode with a capillary temperature of 320C, and with a potential of
2300 V applied to the frit. All data were acquired with the MS operat-
ing in automatic data-dependent switching mode. A high resolution
(70 000) MS scan (300-1600 m/z) was performed using the Q
Exactive to select the eight most intense ions prior to MS/MS analysis
using high-energy collision dissociation.
2.6 | MS data analysis
Raw data from MS analysis was processed using MaxQuant soft-
ware33,34 version 1.5.5.1 and spectra searched using the built in
Andromeda search engine35 with the Uniprot FASTA validated Mus
musculus database being used as the forward database and the
reverse for the decoy search being generated within the software. A
minimum six amino acid length criteria was applied and the false dis-
covery rate (FDR) for MS data analysis was set to 1% at the peptide
and protein level. Cysteine carbamidomethylation was included as a
fixed modification and oxidation of methionine and protein N-terminal
acetylation were set as variable modifications for the peptide search.
The “match between runs” algorithm was used to transfer peptide
identifications between MS runs where possible to increase total
number of protein hits. At least one unique or razor peptide was
required per protein group for identification. Label-free quantification
(LFQ) was carried out using the MaxLFQ algorithm36 within the soft-
ware, with Fast LFQ being disabled. Other settings were kept as
default in the software.
2.7 | EV isolation from conditioned media
Medium from statically and dynamically cultured osteocytes was col-
lected and centrifuged at 3000g for 10 minutes to remove debris.
Medium was then filtered through a 0.45 μm pore filter. Medium was
subsequently ultracentrifuged at 110 000g for 75 minutes at 4C,
using an SW32.Ti swing bucket rotor. Collected EV pellets were
washed in PBS and the ultracentrifugation process was repeated.
2.8 | Characterization of EVs
2.8.1 | Transmission electron microscope imaging
EV imaging was conducted via a JEOL JEM1400 transmission electron
microscope (TEM) coupled with an AMT XR80 digital acquisition sys-
tem. Samples were physiosorbed to 200 mesh carbon-coated copper
formvar grids and negatively stained with 1% uranyl acetate.
2.8.2 | Immunoblotting
For immunoblotting, cell pellets and EVs were lysed using cell extrac-
tion buffer (Invitrogen, Carlsbad, California) supplemented with prote-
ase inhibitor cocktail (Roche, Basel, Switzerland). Protein
quantification was performed using Bio-Rad protein assay (Bio-Rad,
Hercules, California). Cellular and EV protein (8 μg) were resolved on
10% SDS gels and transferred to polyvinylidene difluoride (PVDF)
membranes (BioRad). Blots were incubated at 4C overnight with
monoclonal primary antibodies to GRP-94 (clone D6X2Q, Rabbit mAb
#20292s from Cell Signaling, 1:2000 dilution), TSG101 (clone 4A10,
mouse mAb #ab83 from Abcam, 1:1000 dilution), and PDC6I/ALIX
(clone 3A9, mouse mAb #ab117600 from Abcam, 1:1000 dilution).
Secondary antibodies were incubated for 1 hour at room temperature
and developed using Immobilon Western Chemiluminescent horse-
radish peroxidase (HRP) substrate (Millipore, Massachusetts).
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2.8.3 | Quantification of EV content in conditioned
medium
As a surrogate of EV quantities, protein contents were measured
using a BCA protein assay kit (Thermo Scientific, 23 227). Bovine
serum albumin (BSA) standards (10 μL) were added to a 96 well plate
after which 200 μL of working reagent was added (50:1 ratio of
reagents A and B). EV samples were diluted in CST lysis buffer (Cell
Signaling Technology, 9803), vortexed, and incubated for 1 hour on
ice. Ten microliters of sample lysates were added to the plate and
mixed with 200 μL of working reagent. The plate was incubated for
30 minutes at 37C and absorbance read on a spectrophotometer at
562 nm. BCA assay results combined with the volume of the isolate
were used to calculate the total quantity of protein in the EV isolates
and this value was used to calculate the original concentration of EV
protein in the conditioned medium.
2.8.4 | Particle sizalysis
Particle size analysis was performed on EV samples using a NTA
NS500 system (NanoSight, Amesbury, UK). EV samples were diluted
1:50 in PBS and injected into the NTA system, which obtained
4 × 40 second videos of the particles in motion. Videos were then
analyzed with the NTA software to determine particle size.
2.9 | Uptake of EVs by MSCs
For fluorescent labeling, 2 μg of EVs were incubated with 2 μM
PKH26 dye solution (PKH26GL, Sigma) for 5 minutes, after which
staining was inhibited via addition of 1% BSA solution for 1 minute.
Labeled EVs were pelleted, the excess dye solution aspirated, and
washed twice with culture medium. hMSCs were seeded at a density
of 10 000 cells/cm2 in Nunc glass-bottomed dishes (150680, Thermo
Fisher) and cultured for 24 hours. Cells were washed with PBS before
being incubated with either PKH26-labeled EVs or a dye control con-
taining no PBS with no EVs. Cells were fixed after 18 hours and sta-
ined with Alexa Fluor 488 phalloidin (1:40) (A12379, Thermo Fisher)
and 40,6-diamidino-2-phenylindole (DAPI) (1:2000) (D9542, Sigma) to
label the actin cytoskeleton and nuclei before mounting with Fluo-
roshield (F6182, Sigma) and imaged using confocal microscopy.
2.10 | Assessing osteogenic differentiation of
MSCs via ALP activity
To assess osteogenic differentiation of hMSCs, cells were seeded at a
density of 2500 cells/cm2 in 24 well plates and cultured for 7 days
with control medium containing 2% FBS and 1% PS, minimum
ostegenic medium containing 10 nM dexamethasone, 0.025 mM L-
ascorbic acid and 10 mM β-glycerol phosphate. These concentrations
represent minimal levels for the support of osteogenesis.32,37 The role
of EVs was evaluated by supplementing the minimum osteogenic
medium during seeding and at each medium change with EV-S, EV
depleted CM-S, EV-F, or EV depleted CM-F. For EV groups, a total of
1 μg EVs were added to each well in 24-well plates. Extracellular ALP
at days 3 and 7, and intracellular ALP at day 7 were quantified using a
SigmaFast p-nitrophenyl phosphate (pNPP) kit (N1891, Sigma-
Aldrich). Standard curves were constructed using serial dilutions of
p-Nitrophenyl phosphate (pNPP, Sigma Aldrich, N1891) with 10 μL of
43 μM ALP enzyme (Sigma Aldrich, P6774) in 96-well plates. For test
samples, 50 μL of 5 mM pNPP was added to each well, with 40 μL cell
lysate or cell culture medium being added followed by 40 μL ddH20.
Samples were incubated for 1 hour in the dark at room temperature,
after which reactions were stopped using 20 μL of 3 M NaOH and the
plate was read at 405 nm. ALP activity was calculated as the amount
of pNPP generated by samples, divided by sample volume and reac-
tion time. Intracellular ALP groups were normalised to DNA content
as measured using a Quant-iT PicoGreen dsDNA Assay Kit (Invi-
trogen, P7589), with excitation and emission wavelengths of 485 nm
and 528 nm, respectively.
2.11 | Statistical analyses and bioinformatics
Statistical analysis on recruitment and gene expression data was car-
ried out using one-way analysis of variance (ANOVA) and Bonferroni's
multiple comparison post-test (*P < .05, **P < .01, ***P < .001.
&&&P < .001 of positive control compared to all other groups).
Bioinformatic analysis was performed using Perseus 1.5.5.338 to
analyses LFQ data from MaxQuant. Potential contaminants, proteins
identified in the decoy reverse database, and proteins identified only
by site modification were omitted. LFQ values were transformed
using a log2(x) function. For clustering and principal component analy-
sis (PCA), imputation was carried out (width = 0.3, down shift = 1.8)
where missing values were replaced by values from a normal distribu-
tion. For hierarchical clustering, log transformed intensities were nor-
malized by z-score and clustered using the Euclidean distance method
for both columns and rows. Pathway enrichment analysis of clusters
was carried out using a Fisher's exact test with the Benjamini-
Hochberg FDR threshold set to 5%, with gene ontology cellular com-
ponent (GOCC), biological process (GOBP), molecular function
(GOMF), and UniProt keywords being analyzed for enrichment. A Stu-
dent's t test with a permutation-based FDR (1, 15, 40%) was carried
out to identify differences in expression of proteins between groups,
and volcano plots constructed with difference (log2 fold change) on
the x-axis and significance (−log10 transformed) on the y-axis. The dif-
ference on the x-axis corresponds to the difference between the
mean expression values of log2 transformed data, where a difference
of n corresponds to fold change of 2n. Pathway enrichment analysis
was carried out these significantly upregulated proteins using the
Fisher's exact test with Benjamini-Hochberg FDR cutoff of 5%.
Results were represented as word clouds, with the size of the word
representing degree of enrichment and color representing FDR
corrected p value. All terms with a minimum of 0.5 enrichment factor
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were included. StringDB39 was used to generate protein-protein inter-
action networks of differentially expressed proteins and perform func-
tional enrichment analysis of gene ontology and protein family (Pfam)
terms. For further analysis between CM-S and CM-F groups, only pro-
teins that were identified in all three biological replicates if at least
one of the groups were considered for further analysis.
3 | RESULTS
3.1 | Osteocytes regulate human MSC recruitment
and osteogenesis in response to fluid shear
hMSCs were cultured in conditioned medium collected from stati-
cally (CM-S) and dynamically (CM-F) cultured osteocytes, with
recruitment and osteogenic gene expression being investigated (Fig-
ure 1A). A trend of increased hMSC recruitment toward CM-S com-
pared to control medium was observed; however, this was not
significant. CM-F did, however, enhance MSC recruitment; an effect
that was significantly greater than with either medium (3.2-fold;
P < .001, n = 9) or CM-S (1.8-fold; P < .01, n = 9), indicating the
enhanced chemotaxis displayed by MSCs toward mechanically stim-
ulated osteocytes. The role of osteocyte paracrine signaling in driv-
ing osteogenesis was also investigated by treating hMSCs with CM-
S or CM-F for 24 hours and investigating expression of osteogenic
genes COX2, OCN, OPN, RUNX2, and OSX (Figure 1B). Treatment
with CM-S did not significantly alter expression of any of the inves-
tigated genes in hMSCs compared to medium. hMSCs cultured in
CM-F resulted in consistently increased expression of all genes eval-
uated, with significant fold changes of 4.6 in COX2, 5.4 in OPN,
and 3.4 in RUNX2 compared to medium (P < .001, n = 4-6). These
genes were also significantly upregulated with CM-F compared to
CM-S with 3.0-fold, 2.2-fold, and 2.3-fold changes, respectively
(P < .01-.001, n = 4-6). There was a near-significant 3.1-fold
increase in OSX with CM-F compared to medium (P = .07, n = 4-6),
in addition to a 2.5-fold increase in OCN expression in CM-F com-
pared to CM-S. In summary, CM-S elicits marginal increases in
hMSC osteogenesis, with significant increases following CM-F treat-
ment, supporting the importance of mechanical loading in mediating
osteocyte-MSC mechanosignaling.
3.2 | Overview of identified proteins within the
osteocyte secretome
Analysis of the osteocyte secretome revealed a total of 393 pro-
teins across all groups. Within these groups, over 300 proteins
were identified in both the CM-S and CM-F groups, with 112 being
identified in Medium control (Figure 2C), with all proteins being
listed in Supporting Information Table A. Pearson correlations, com-
paring all biological replicates to one another, show that there is a
high average correlation between replicates in the CM-S (0.92) and
CM-F (0.90) groups (Figure 2D). When comparing CM-S and CM-F
to one another, an average correlation of 0.90 is seen, revealing a
significant degree of similarity in protein expression between oste-
ocytes cultured in static and dynamic conditions. In contrast, when
comparing CM groups (CM-S and CM-F) to Medium, an average
correlation of 0.33 was seen between them, demonstrating the dif-
ference in the osteocyte secretome and osteocyte culture media
indicating the release of proteins into culture medium from the
osteocyte.
3.3 | Proteomic analysis of the osteocyte
secretome reveals enrichment of proteins associated
with EVs
Hierarchical clustering revealed three primary groups of protein
expression within the samples. CM-S and CM-F groups comprise one
of the main clusters (Figure 3A), where it can be seen that there is
F IGURE 1 Role of osteocyte conditioned medium on hMSC osteogenesis. A, Migration of human bone marrow stem/stromal cell (hMSCs)
toward osteocyte conditioned medium and normalized to Medium, showing significant increases in chemotactic index towards CM-F medium
when compared to CM-S (n = 9). B, quantitative polymerase chain reaction (qPCR) analysis of COX-2, OCN, OPN, RUNX2, and OSX expression in
hMSCs treated with osteocyte medium from CM-S and CM-F (n = 4-6). Statistical analysis using one-way analysis of variance (ANOVA) and
Bonferroni's multiple comparison post-test for chemotactic index (*P < .05, **P < .01, ***P < .001, &&&P < .001 vs Medium and EV-S)
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considerable similarity of protein content in terms of LFQ intensity
within these groups. Medium samples comprise the remaining column
clusters, where the reduced number and expression of proteins are
more apparent when considering data without imputation (Figure 3B).
Due to the similarity between osteocyte conditioned medium groups,
also verified via PCA (Figure S2), an analysis was first undertaken by
combining CM-S and CM-F (termed CM), and comparing it to Medium
to identified the proteins which comprise the osteocyte secretome.
The results of this reveal the presence of 97 proteins which have sig-
nificant differential expression in CM, indicated in red in Figure 3C,
and listed in Table 1. Within these proteins, significant enrichment
(enrichment factor > 1.7, P < 10-4) of several “extracellular” GOCC
terms was shown in comparison to the total 393 identified proteins
using Fisher's exact test, with enrichment of UniProt keywords
“secreted” and “signal” (enrichment factor > 1.6, P < 10-5) also
occurred (Figure 3D). This validates the successful isolation of pro-
teins released by the osteocyte into their surrounding environment,
with evidence for further downstream signaling functions. Functional
enrichment within CM proteins of GOCC terms with reference to the
whole Mus musculus genome further reported the significant enrich-
ment of membrane-bound vesicles and exosomes in the secretome
(Table S2). This suggested a potential role for EVs, and in particular
exosomes (FDR < 10-40), in transporting signaling factors, either
protein to RNA based, released by osteocytes. Functional enrichment
of GOBP, GOMF, and Pfam terms was also investigated, showing sig-
nificant roles for these proteins in mechanosensensing and
mechanosignaling, as evidenced by the most significantly enriched
terms “response to stress” (FDR < 10-6) and “protein complex binding”
(FDR < 10-8). The interaction network between identified proteins in
the osteocyte secretome reveals a highly significant degree of pro-
tein-protein interaction (P < 10-16) as illustrated in Figure S1. Enrich-
ment analyses was also conducted on proteins more abundantly
expressed in the control Medium samples using Fisher's exact test
(Figure S3) and functional enrichments (Table S4), revealing enrich-
ment of muscle and cytoskeletal terms. These associations are likely
due to the incorporation of proteins from rat tail collagen type 1 used
for coating glass slides.
3.4 | Mechanical stimulation alters the protein
release characteristics in osteocytes
Subsequent analysis separating the CM-S and CM-F groups showed
that different proteins were released from statically cultured and
mechanically stimulated osteocytes, highlighting the role of external
mechanical forces in regulating the osteocyte secretome. The more
F IGURE 2 Outline of experiment procedure. MLO-Y4 cells were seeded to collagen coated glass slides and cultured for 48 hours (A), before
being transferred to parallel plate flow chambers for dynamic (OFF, 1 Pa, 1 Hz, 2 hours) or static culture. The slides were then transferred to
culture dishes and 2.5 mL of serum free medium was applied, with a control group being present with collagen coated glass slides without cells.
The serum-free medium was collected and centrifuged to remove debris. One milliliter of each sample was collected, and proteins were
precipitated and digested in solution before being purified via C18 stage tips (B). Samples were analyzed via liquid chromatography-mass
spectrometry and tandem mass spectrometry (LC-MS/MS), and label-free quantification was carried out in MaxQuant before a bioinformatic
analysis was completed in Perseus (&&&P < .001 vs Medium using one-way analysis of variance (ANOVA) and Bonferroni's multiple comparison
post-test) (C). Pearson correlations between technical replicates, biological replicates, and sample groups were determined, with correlations
between biological replicates with combined technical replicates shown (D)
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stringent criteria of only considering proteins identified in all three
biological replicates in at least one of the groups reduced the total
number of proteins of interest to 317. A total of 34 proteins were
identified with varying degrees of significance and differential
expression between groups, with 32 of these indicated on a volcano
plot (Figure 4A), and a further two not present on the plot due to
being present in only one of the CM groups. LFQ intensities of
some of the most differentially expressed proteins with greater
expression in CM-S (Figure 4B-D) or CM-F (Figure 4E,F) are
highlighted. Of note is the enrichment of 14-3-3 proteins, all of
which are upregulated in CM-F (log2 fold change = 1.43-2.33). Of
particular interest are annexin A5 (log2 fold change = 2.39), which
is associated with EVs and blood microparticles suggesting a role in
systemic signaling, and histone H4 (log2 fold change = 2.00) which
is associated with osteogenic growth peptide (OGP) and known to
stimulate osteoblast activity.40
Subsequently, functional enrichment in differentially secreted
proteins between CM-F and CM-S was investigated to help further
elucidate their collective biological relevance in mechanically medi-
ated osteocyte signaling (Table S3). The top four enriched GOCC
terms: extracellular region, membrane-bounded vesicle, extracellular
region part, and extracellular exosome are associated with EV proteins
with a highly significant FDR (<10-10). 65% to 76% of all differentially
secreted proteins were associated with these terms. This confirms
that EVs are not only implicated in the osteocyte secretome, as dem-
onstrated above, but are a key component of mechanically mediated
signaling. Also, of substantial interest is the enrichment of the top two
GOMF terms “calcium ion binding” (FDR < 0.01) and “phosphoserine
binding” (FDR < 0.05), revealing the potential role of mechanically
activated osteocyte EVs as sites of mineralization via binding of cal-
cium and phosphate components, which has been previously postu-
lated.20,24 A String DB network was constructed to further investigate
F IGURE 3 Proteomic analysis of the osteocyte secretome. Hierarchical clustering of all samples with imputed data (A) and hierarchical
clustering in the control samples without imputation of data (B). Volcano plot illustrating proteins significantly upregulated proteins marked in red
in CM-S and CM-F groups compared to the control (C). Enrichment analysis of GOCC terms and Uniprot keywords in upregulated proteins using
Fisher's exact test represented as a word cloud (D). The size of the word represents enrichment of terms, while color represents FDR corrected
P value. All terms with a minimum of 0.5 enrichment factor and 0.05 FDR corrected P value were included. FDR, false discovery rate
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any potential interactions between proteins associated with EVs
(Figure 4H) revealing a significant degree of protein-protein interac-
tion (P < 10-3). Interestingly, there are several interactions between
positively and negatively regulated proteins, including an interaction
path between Anxa5 and Ywhab/Ywhae which are associated with
calcium ion binding and phosphoserine binding, respectively. Between
these nodes are gelsolin and cofilin, the former of which is calcium-
sensitive and both of which have been shown to regulate changes in
the actin cytoskeleton,41 as well as occurring in vesicles from mineral-
izing osteoblasts.42
3.5 | EVs are present within the osteocyte
secretome and EV morphology and size distribution is
not altered by mechanical stimulation
Given the identification of EV-associated proteins within the osteo-
cyte secretome, we next investigated whether osteocytes release EVs
and, if so, whether EV characteristics were altered by mechanical
stimulation. EVs were successfully separated from osteocyte CM
using filtration and ultracentrifugation, with the presence of EVs con-
firmed by TEM imaging and immunoblotting. TEM imaging confirmed








Rpl8 60S ribosomal protein L8 28.024 0 +
Clic4 Chloride intracellular channel protein 4 28.729 3.328 +
Anxa5 Annexin A5 35.752 2.390 **
Ywhae 14-3-3 protein epsilon 29.174 2.327 ***
Rps18 40S ribosomal protein S18 12.483 2.177 *
Hist2h4 Histone H4 11.367 2.001 *
Ywhab 14–3-3 protein beta/alpha 28.086 1.917 ***
Ywhaz 14–3-3 protein zeta/delta 27.771 1.892 **
Dbi Acyl-CoA-binding protein 10.000 1.878 *
Ywhag 14–3-3 protein gamma 28.302 1.827 **
Try10 MCG140784 26.221 1.762 **
Igf2 Insulin-like growth factor II 11.107 1.760 *
Hist1h2bk Histone H2B 13.920 1.666
Ptms Parathymosin 11.430 1.541 **
Sh3bgrl3 SH3 domain-binding glutamic acid-rich-like protein 3 10.477 1.489 ***
Ywhaq 14-3-3 protein theta 32.221 1.434 **
Tmsb10 Thymosin beta-10 5.026 1.387 **
Erh Enhancer of rudimentary homolog 12.259 1.126 **
Ftl1 Ferritin; Ferritin light chain 1; Ferritin light chain 2 20.772 1.110 **
Inhba Inhibin beta A chain 47.392 0.986 **
Myl12b Myosin regulatory light chain 12B 19.895 0.954 **
Myl6 Myosin light polypeptide 6 16.930 0.918 *
Col1a2 Collagen alpha-2(I) chain 129.560 0.874 **
Cfl1 Cofilin-1 18.559 0.861 **
Gsn Gelsolin 85.941 −0.925 **
Pgm1 Phosphoglucomutase-1 61.417 −1.135 *
Psmd3 26S proteasome non-ATPase regulatory subunit 3 60.718 −1.158 ***
Aebp1 Adipocyte enhancer-binding protein 1 128.360 −1.319 ***
C1ra Complement C1r-A subcomponent 80.072 −1.437 *
Thbs2 Thrombospondin-2 129.880 −1.723 *
Efemp1 EGF-containing fibulin-like extracellular matrix protein 1 54.952 −1.732 *
Efemp2 EGF-containing fibulin-like extracellular matrix protein 2 49.425 −1.743 ***
Mdh2 Malate dehydrogenase, mitochondrial 35.611 −2.056 *
Npm1 Nucleophosmin 28.385 0 +
Note: *P < .1, **P < .05, ***P < .01 and “+” indicates proteins with only a single or no detection in CM-S group (top of table) and no detection in CM-F group
(bottom of table) where P value cannot be defined.
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the presence of EVs of typical morphology and size (Figure 5A,B). The
presence of EVs was further confirmed via immunoblotting, with no
detection of negative marker GRP-94, and detection of positive
markers TSG101 and ALIX (Figure 5C). EV concentration was not
significantly different between EVs separated from the CM-S (EV-S)
and EVs separated from the CM-F (EV-F), both being within the range
of 0.8-2.6 μg/mL, and with average values of 1.2 μg/mL and 1.5 μg/
mL, respectively (Figure 5D). It can be seen that there is a change in
F IGURE 4 Quantifying differences between the static and dynamic osteocyte secretome. A, Volcano plot, illustrating upregulation with flow
to the right and downregulation to the left. The y-axis displays the -log10 of P value, where the horizontal line corresponding to a P value of .1.
Vertical lines indicate a log2 fold change of ±1. Curves illustrate indicated FDR values with S0 parameter set to 2. B-D, Whisker plots of three
significantly upregulated proteins and E-G significantly downregulated proteins in the presence of fluid flow are indicated. The arrow indicates a
protein which displays low significance due to being present in only one of the CM replicates. H, String DB network illustrating interactions
between mechanically regulated proteins, with significant degree of protein-protein interaction (P < 10-3). CM, conditioned medium; FDR, false
discovery rate
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F IGURE 5 Characterization of EVs and their influence on hMSC osteogenesis. TEM image of EVs isolated from osteocyte CM-S (A) and CM-
F (B). C, Immunoblots confirmed the presence of EVs via negative marker GRP-94 and positive markers TSG101 and ALIX. D, Protein
concentration of EVs in conditioned medium groups (n = 5). Nanoparticle size analysis on EVs confirmed no significant difference in distribution
(E) or average size (F) between groups (n = 4). G, Immunofluorescent images illustrating osteocyte EV uptake by human bone marrow stem/
stromal cell (hMSCs), as demonstrated by localization of PKH26 labeled EVs within the cell body (scale bar = 10 μm). H, Migration of hMSCs
toward EVs isolated from osteocyte conditioned medium and normalized to Medium, showing significant increases in chemotactic index toward
CM-F medium when compared to CM-S. I, Quantitative polymerase chain reaction (qPCR) analysis of COX-2, OCN, OPN, RUNX2, and OSX
expression in hSSCs treated with EVs from osteocyte medium from CM-S and CM-F. Statistical analysis using one-way analysis of variance
(ANOVA) and Bonferroni's multiple comparison post-test (*P < .05, **P < .01, ***P < .001, &&&P < .001 vs Medium and EV-S). EVs, extracellular
vesicles; TEM, transmission electron microscope
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F IGURE 6 Long-term study of influence of EVs on human bone marrow stem/stromal cell (hMSC) osteogenesis. A, Summary schematic of
experimental procedure and outputs. Intracellular ALP activity at day 7 (B), with a comparison of EV groups with EV depleted conditioned
medium (C). Extracellular ALP activity at day 3 (D) with a comparison of EV groups with EV depleted conditioned medium (E). Extracellular ALP
activity at day 7 (F) with a comparison of EV groups with EV depleted conditioned medium (G). All data n = 6. Statistical analysis using one-way
analysis of variance (ANOVA) and Tukey's multiple comparison post-test (*P < .05, **P < .01, ***P < .001, &&&P < .001 of indicated group vs all
other groups). ALP, alkaline phosphatase; EVs, extracellular vesicles
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particle size distributions between EV-S and EV-F (Figure 5E); how-
ever, no changes in average particle size was detected, with values of
177 nm and 183 nm, respectively (Figure 5F).
3.6 | Osteocytes regulate human MSC recruitment
and osteogenesis in response to fluid flow shear via
MA-EVs
To determine whether murine osteocyte-derived EVs could be taken
up by human MSCs, we labeled EVs with PKH26. Following 24 hours
treatment, labeled-EVs were preferentially located within the cyto-
plasm, indicating uptake of EVs by hMSCs (Figure 5G). Control sam-
ples are illustrated in Figure S4. A high density of EVs can be seen
around the nuclear region in particular with minimal detection within
the nucleus.
Upon verifying EV uptake, the cellular response of hMSCs sub-
jected to EVs separated from CM-S (ie, EV-S) or CM-F (EV-F) was
investigated. Specifically, hMSCs were treated with EV-S and EV-F to
investigate recruitment and osteogenic gene expression as previously
demonstrated with CM. EV-S resulted in a slight nonsignificant
increase in MSC recruitment (Figure 5H), while this response was sig-
nificantly enhanced with EV-F, yielding a 3.7-fold increase compared
to medium (P < .001, n = 9) and 2.3-fold increase compared to EV-S
(P < .01, n = 9). This trend closely mirrored that seen with whole
secretome. Osteogenic gene expression (Figure 5I) showed a consis-
tent trend of marginally increased expression with CM-S treatment,
which was further enhanced with CM-F. There was a near-significant
increase of 1.5-fold in OPN (P = .051, n = 17-18) when comparing
CM-S to Medium. CM-F resulted in significant changes compared to
medium of 2.0-fold in COX2 (P < .05, n = 17-18), 1.8-fold in OCN
(P < .05, n = 14-15), 2.0-fold in OPN (P < .001, n = 16-18) and 1.5-fold
in RUNX2 (P < .05, n = 20), with a near-significant increase of 2.6-fold
in OSX (P = .07, n = 21-23). In addition, near-significant increases in
OCN and OPN were detected comparing EV-F and EV-S. Moreover,
orthology searches using the basic local alignment search tool
BLAST43 were performed for the human gene sequences (COX2,
OCN, OPN, RUNX2, OSX) in the murine genome (version: Mus
musculus GRCm38.p4). The bioinformatic tool, in silico PCR (UCSC
Genome Browser), was used to confirm the lack of amplification of
the human primer sequences in the murine genome,44 confirming that
amplified genes are human, and not due to possible transfer of murine
mRNA from the MLO-Y4 cell line. In summary, there is a trend of
increasing osteogenesis in hMSC following EV-S treatment. However,
this affect becomes significantly greater with EV-F treatment, show-
ing a similar trend to that seen with whole secretome and demon-
strates that EVs from mechanically-activated osteocytes are key
drivers of stem cell recruitment and osteogenesis.
To further investigate the role of EVs in later stage differentiation,
hMSCs were cultured up to 7 days, with intracellular ALP being inves-
tigated at day 7 and extracellular ALP being investigated at day 3 and
day 7. This was conducted on both EVs and EV depleted medium to
investigate how other non-EV associated factors within the medium
affect osteogenesis (Figure 6A). Intracellular ALP activity was signifi-
cantly enhanced at day 7 with EV-F vs EV-S in addition to all other
groups (Figure 6B), while it was also demonstrated that EV-F signifi-
cantly enhanced ALP activity compared to both static and flow EV
depleted medium (Figure 6C), which is consistent with trends seen
with earlier gene expression. Extracellular ALP was also assessed from
the medium change at day 3, in addition to the end of the experiment
at day 7. There were no significant differences between any groups at
day 3 (Figure 6D,E). However, at day 7 it can be seen that EV-F is sig-
nificantly enhanced compared to EV-S (Figure 6F). Interestingly, while
there is an increase in extracellular ALP in the EV-F compared to the
EV depleted CM-F, this is not significant (Figure 6G). Taken together,
this data demonstrate that EVs isolated from mechanically activated
osteocytes can enhance the osteogenesis of hMSCs.
4 | DISCUSSION
Osteocytes are mechanosensitive cells which play a fundamental role
in coordinating loading-induced bone formation via the secretion of
paracrine factors which drive effector cell behavior. One of the most
important of which are bone marrow stem/stromal cells (MSCs) which
are responsible for replenishing the bone forming osteoblast popula-
tion. However, the exact mechanisms by which osteocytes relay
mechanical signals to these cells are poorly understood. A greater
understanding of these mechanisms would thus have profound impli-
cations for the development of therapies to treat the wide range of
diseases with which the osteocyte has been linked, one of the most
devastating of which is osteoporosis. Therefore, this study aimed to
demonstrate the potency of the mechanically stimulated osteocyte
secretome in driving human MSC behavior, and fully characterize its
protein content with the aim of identifying the key secreted factors
regulating bone mechanobiology. Herein, we demonstrate that osteo-
cytes subjected to oscillatory fluid shear secrete factors that signifi-
cantly enhance hMSC recruitment and osteogenesis. To uncover the
osteocyte derived secreted factors which drive hMSC behavior, we
performed a proteomic analysis of the osteocyte secretome to
uncover an extensive map of proteins which are released both under
static conditions and following mechanical stimulation. Over 300 pro-
teins comprising the osteocyte secretome were identified with 34
proteins differentially expressed following mechanical stimulation.
The osteocyte secretome was significantly enriched with proteins
associated with EVs and exosomes indicating a role for secreted vesi-
cles in mediated mechanically driven osteocyte-MSC communication.
EVs were subsequently separated from the mechanical activated oste-
ocyte secretome, characterized, and found to elicit similar trends in
MSC recruitment and osteogenesis to that seen with conditioned
media, demonstrating a key role for osteocyte EVs in mediating hMSC
behavior.
Mechanically stimulated osteocytes secrete paracrine factors that
recruit human MSCs and enhance osteogenesis. The ability of
mechanically stimulated osteocytes to influence stem cell behavior is
in agreement with previous findings in vivo where mechanical loading
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of bone results in the recruitment and osteogenic differentiation of
endogenous45 or transplanted exogenous osteoprogenitors.46 Fur-
thermore, a similar trend in recruitment has been shown in murine
MSCs where a 128% increase in stem cell recruitment was observed
following exposure to conditioned media collected from osteocytes
cultured on a rocking platform.10 Interestingly in the same study,
mechanically activated osteocyte conditioned media was also been
shown to induce osteogenesis of MSCs as demonstrated by
upregulation of Opn and Cox-2 gene expression and enhanced min-
eral deposition.10,11 We have demonstrated a comparable increase in
COX-2 and OPN expression in human MSCs, as well as increases in
OCN, OSX and RUNX2. These findings, along with other previous
work investigating the effect of the osteocyte secretome on osteo-
blast proliferation, migration and osteogenesis,9,47 further reinforce
the importance of the osteocyte secretome and its contents in the
indirect biophysical regulation of MSCs and loading-induced bone
formation.48,49
To determine the mechanisms by which osteocytes coordinate
stem cell recruitment and osteogenesis in response to loading, for the
first time, we identified a detailed a map of the osteocyte secretome
via a mass spectrometry based proteomic analysis. Interestingly, a
number of key proteins, such as Sclerostin, which is known to be
secreted by osteocytes, were not detected. This may due to the limi-
tation of the MLO-Y4 osteocyte cell line but given the pro-osteogenic
effect of this mechanically activated osteocyte secretome, this opens
the possibility of identifying novel factors regulating MSC behavior.
We have identified several proteins from a previous proteomic analy-
sis on osteocyte lysates,18 revealing potential roles for these proteins
in cell signaling. Further analysis sought to investigate the role of
mechanical forces on the contents of the osteocyte secretome, with
differential expression of a range of proteins including the 14-3-3 pro-
tein group. Previous studies have implicated these proteins in osteo-
genesis, with downregulation of 14-3-3 beta being demonstrated in
calvaria organ cultures resulting in increased bone formation50 and
increased 14-3-3 epsilon release being demonstrated in osteoblasts/
osteocytes in response to dynamic compression.51 Other proteins of
particular interest are histone H4 and annexin A5. Histone H4 has
been shown to play a role in osteoblast gene expression and osteo-
genesis52,53 while the C-terminus of histone H4, termed OGP plays
key roles in regulating the behavior of bone residing cells.40,54
Annexin A5 has been shown to increase at the cell membrane in addi-
tion to Ca2+ levels in osteoblasts under fluid flow. The disruption of
annexin A5 inhibits Ca2+, implicating its role in calcium signaling,55
with its knockdown impairing osteoblast function.56 One down-
regulated protein of interest which we have identified is throm-
bospondin 2. The knockdown of this protein in mice has been shown
to increase angiogenesis57 and endosteal bone formation58 while
thrombospondin 2 null mice demonstrate enhanced callus bone for-
mation, vascularity and MSC proliferation following tibial fracture.59
In addition to the above, many of the proteins we have identified are
known to be EV cargo, with many also having previously been identi-
fied in osteoblast EVs.42,60 The content of the osteocyte secretome,
in addition to a possible delivery mechanism via EVs, provides us with
a database of information via which to develop targeted therapeutics
for specific bone diseases such as osteoporosis.
The role of EVs in osteocyte signaling to MSCs was investigated
to further investigate the mechanisms behind our previously dis-
cussed findings. EVs were separated from osteocyte conditioned
media, where interestingly, we did not detect any changes in EV mor-
phology or quantity between static and dynamic groups. This is in
contrast to previous work which has demonstrated an upregulation in
EV number following fluid shear stimulation.61 We have however
demonstrated an almost identical trend in stem cell recruitment with
CM and EVs. Stem cell recruitment is enhanced both with medium
from mechanically stimulated osteocytes, and EVs separated from the
same medium, providing evidence for the key role of osteocyte
derived EVs in mediating this response. Similarly, the almost identical
trends in MSC osteogenic gene expression treated with CM and EVs
further provide evidence for the role of osteocyte derived MA-EVs in
facilitating cell-cell communication in bone. We have also demon-
strated further long-term effects of MA-EVs on hMSC osteogenesis,
as seen by the enhanced intracellular and extracellular ALP activity at
day 7 compared to EVs secreted from statically cultured osteocytes.
Given the similar concentrations of EVs between groups, it is
expected that this pro-osteogenic effect is a result of EV content
changing in response to mechanical stimulation. EVs are also known
to act as sites of mineral nucleation, as has been demonstrated in
osteoblasts.20,62 We have also seen evidence for this, with enrichment
of calcium ion binding (such as annexin A5) and phosphoserine bind-
ing (such as 14-3-3 proteins Ywhae and Ywhab) proteins in our prote-
omic analysis. In our protein interaction network, Annexin A5 is linked
to the calcium sensitive protein gelsolin,41 which in turn is linked to
the 14-3-3 proteins via the phosphate regulating cofilin.63 In addition
to the known role of calcium ions in mineralization, negatively charged
amino acids such as phosphoserine are also known to play a key role
in hydroxyapatite nucleation and growth.64 Therefore, osteocyte EVs
may promote mineralization via delivery of calcium and phosphate
interacting proteins through interaction with gelsolin and cofilin,
respectively. Another likely mechanisms in the pro-osteogenic capabil-
ities of EVs are RNAs, specifically miRNAs, with a previous study dem-
onstrating altered miRNA expression in EVs isolated from the plasma
of osteocyte ablated and wild-type mice.25 The potency of EVs in
mediating cell behavior has led others to exploit them for the develop-
ment of therapeutics. For example, EVs have been investigated as a
potential therapy for root canal treatments,65 for the functionalization
of TE scaffolds to enhance bone regeneration,66,67 and as delivery
vehicles for the loading of drugs for osteoporosis therapies.28 Taken
together, we have shown that MA-EVs are a key mechanism by which
osteocyte communicate chemotactic and osteogenic signals to
osteoprogenitors in response to loading, and present themselves as a
potential cell free therapy to mimic the beneficial effect of loading
and enhance bone formation.
In summary, this study presents evidence that the mechanically
stimulated osteocyte secretes factors which coordinates MSC recruit-
ment and osteogenesis demonstrating a mechanism required for load-
ing-induced bone formation. Importantly, for the first time, we have
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mapped the osteocyte protein secretome and determined how this is
altered in response to mechanical stimulation generating a database
of potential factors mediating this mechanism. Last, this study also
demonstrates the presence and fundamental role of MA-EVs released
by osteocytes in coordinating MSC recruitment and osteogenesis,
identifying a novel mechanism by which osteocytes coordinate bone
mechanobiology. Moreover, these pro-osteogenic osteocyte derived
MA-EVs represent a potential cell-free therapy to enhance bone
regeneration and repair in diseases such as osteoporosis.
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